Tim-3 expression is increased on peripheral T cells from diffuse large B cell lymphoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tim-3 expression is increased on peripheral T cells from diffuse large B cell lymphoma
Authors
Keywords
Tim-3, CD4+ T cells, CD8+ T cells, DLBCL
Journal
TUMOR BIOLOGY
Volume 35, Issue 8, Pages 7951-7956
Publisher
Springer Nature
Online
2014-05-15
DOI
10.1007/s13277-014-2080-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pathology Consultation on Intermediate-to-Large B-Cell Lymphomas
- (2014) Nathan D. Montgomery et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Expression of TIM-3 on CD4+ and CD8+ T cells in the peripheral blood and synovial fluid of rheumatoid arthritis
- (2014) Shufeng Li et al. APMIS
- Tim-3 on Peripheral CD4+ and CD8+ T Cells Is Involved in the Development of Glioma
- (2014) Song Han et al. DNA AND CELL BIOLOGY
- Tim-3 expression on peripheral monocytes and CD3+CD16/CD56+natural killer-like T cells in patients with chronic hepatitis B
- (2014) Y.-H. Rong et al. TISSUE ANTIGENS
- The T-cell immunoglobulin and mucin domain (Tim) gene family in asthma, allergy, and autoimmunity
- (2013) Zhenhong Li et al. ALLERGY AND ASTHMA PROCEEDINGS
- BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma
- (2013) D. T. Frederick et al. CLINICAL CANCER RESEARCH
- The Expression of Tim-3 in Peripheral Blood of Ovarian Cancer
- (2013) Jie Wu et al. DNA AND CELL BIOLOGY
- Therapeutic gene modified cell based cancer vaccines
- (2013) Anna Kozłowska et al. GENE
- Restoring Immune Function of Tumor-Specific CD4+ T Cells during Recurrence of Melanoma
- (2013) S. R. Goding et al. JOURNAL OF IMMUNOLOGY
- Molecular signatures of T-cell inhibition in HIV-1 infection
- (2013) Marie Larsson et al. Retrovirology
- T-cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and prognosis of non-small-cell lung cancer
- (2013) Jianwen Bai et al. TUMOR BIOLOGY
- Molecular classification, pathway addiction, and therapeutic targeting in diffuse large B cell lymphoma
- (2013) Soham Puvvada et al. Cancer Genetics
- Ectopic Expression of TIM-3 in Lung Cancers
- (2012) Xuewei Zhuang et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- TIM-3 as a therapeutic target for malignant stem cells in acute myelogenous leukemia
- (2012) Yoshikane Kikushige et al. Annals of the New York Academy of Sciences
- Tim-3, a negative regulator of anti-tumor immunity
- (2012) Ana Carrizosa Anderson CURRENT OPINION IN IMMUNOLOGY
- T cell immunoglobulin-3 as a new therapeutic target for rheumatoid arthritis
- (2012) Xia Li et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway
- (2012) Rodrigo Liberal et al. HEPATOLOGY
- TIM-3 Expression Characterizes Regulatory T Cells in Tumor Tissues and Is Associated with Lung Cancer Progression
- (2012) Xin Gao et al. PLoS One
- Tim-3 Negatively Regulates Cytotoxicity in Exhausted CD8+ T Cells in HIV Infection
- (2012) Ali Sakhdari et al. PLoS One
- Emerging Tim-3 functions in antimicrobial and tumor immunity
- (2011) Kaori Sakuishi et al. TRENDS IN IMMUNOLOGY
- Tim-3 expression on peripheral T cell subsets correlates with disease progression in hepatitis B infection
- (2011) Wei Wu et al. Virology Journal
- Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+T cell dysfunction in melanoma patients
- (2010) Julien Fourcade et al. JOURNAL OF EXPERIMENTAL MEDICINE
- T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B
- (2010) Ying Ju et al. JOURNAL OF HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More